MACROGENICS INC (MGNX)
MACROGENICS INC (MGNX)
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenues | -87,498 | NaN | 108,273 | NaN |
| Cost of product sales | NaN | NaN | 0 | NaN |
| Cost of manufacturing services | -16,364 | NaN | 25,894 | NaN |
| Research and development | -78,224 | NaN | 113,198 | NaN |
| General and administrative | -20,215 | NaN | 29,925 | NaN |
| Other non-cash items | NaN | 0 | 0 | 0 |
| Other segment income (loss), net | 3,614 | NaN | -279 | NaN |
| Net loss | -36,774 | -14,155 | 16,822 | -77,287 |
| Depreciation and amortization | 1,687 | 1,705 | 1,789 | 3,678 |
| Amortization of premiums and discounts on marketable securities | 737 | 644 | 511 | 493 |
| Share-based compensation expense | 2,646 | 2,661 | 3,549 | 8,076 |
| Gain on royalty monetization arrangement | NaN | -3,333 | 3,333 | NaN |
| Gain on sale of margenza | NaN | 0 | NaN | NaN |
| Non-cash royalty revenue | 6,151 | 7,932 | NaN | NaN |
| Non-cash interest expense recognized | 4,864 | 4,343 | 3,329 | 587 |
| (gain) loss on disposal of assets | NaN | 10 | NaN | NaN |
| Non-cash lease expense | 424 | 580 | 405 | 799 |
| Accounts receivable | -2,947 | -55,858 | 56,698 | 8,223 |
| Inventory | 1,589 | -840 | -525 | 9,275 |
| Prepaid expenses and other current assets | -374 | 1,031 | 1,062 | -4,862 |
| Other non current assets | 0 | 164 | -5 | -159 |
| Accounts payable | -776 | -1,201 | 1,309 | -388 |
| Accrued expenses and other current liabilities | -3,719 | -921 | 1,738 | -7,651 |
| Lease liabilities | -252 | -247 | -238 | -214 |
| Deferred revenue | 1,569 | 282 | 2,525 | -8,205 |
| Other non current liabilities | -324 | -276 | -340 | -300 |
| Net cash used in operating activities | -35,811 | 43,021 | -30,186 | -93,875 |
| Proceeds from sale of margenza | NaN | 0 | NaN | NaN |
| Proceeds from sales of equipment | NaN | 11 | 0 | 0 |
| Purchases of marketable securities | 1,980 | 88,846 | 66,062 | 53,428 |
| Proceeds from maturities of marketable securities | 47,642 | 23,089 | 46,117 | 26,936 |
| Purchases of property, equipment and software | 344 | 244 | 426 | 1,244 |
| Net cash provided by investing activities | 45,318 | -65,990 | -20,371 | -27,736 |
| Proceeds from issuance of common stock, net of offering costs | NaN | 0 | NaN | NaN |
| Proceeds from stock option exercises and espp purchases | 11 | 63 | 0 | 66 |
| Taxes paid related to net share settlement of equity awards | 218 | 6 | 0 | 282 |
| Principal payments on royalty monetization arrangement | NaN | 0 | NaN | NaN |
| Net proceeds from sale of future royalties | NaN | 0 | 0 | 69,673 |
| Net cash used in financing activities | -207 | 57 | 0 | 69,457 |
| Net change in cash and cash equivalents | 9,300 | -22,912 | -50,557 | -52,154 |
| Cash and cash equivalents at beginning of period | 57,217 | 80,129 | 182,840 | NaN |
| Cash and cash equivalents at end of period | 66,517 | 57,217 | 80,129 | NaN |